Functional Imaging of Psychic Pain

NCT01493323 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2014-12-04

No results posted yet for this study

Summary

Suicidal behaviour (SB) represents a major public health problem, costing life in more that one million people every year worldwide. Even if SB is considered as a consequence of social adversity and depression, these stress factors are often necessary but not sufficient to explain the occurrence of a suicidal act. A preliminary study suggests that an increased perception of psychic pain during a major depressive disorder increases the risk of suicide behaviour. The investigators aimed to investigate the relationship between social exclusion (a classic trigger of psychic pain) and SB and improve our knowledge about the physiopathology of this domain.

Conditions

  • Suicide, Attempted
  • Mood Disorder

Interventions

BEHAVIORAL

Assessment of personality traits

suicide behaviour , psychic pain, social exclusion, decision making...

BEHAVIORAL

Assessment of suicidal act

suicide behaviour , psychic pain, social exclusion, decision making...

BEHAVIORAL

Assessment of depression

suicide behaviour , psychic pain, social exclusion, decision making...

PROCEDURE

Cyber ball game

functional neuroimaging

PROCEDURE

Iowa Gambling Task

functional neuroimaging

PROCEDURE

Microcomputer

functional neuroimaging

PROCEDURE

blood sample

blood sample

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER
  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Philippe PC Courtet, Professor(MD-PhD) · University Hospital, Montpellier

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-08-31
Completion
2014-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01493323 on ClinicalTrials.gov